Characterizing the burden of bacterial meningitis in Central America: evidence from national surveillance records

Background Bacterial meningitis remains a public health concern, yet countries in Central America lack published national epidemiological descriptions. Methods In a retrospective population-based study, ICD-10 -coded national hospital discharge and mortality databases from Honduras (2014 -2024) and reference-laboratory surveillance data (INCIENSA/SIREVA II) from Costa Rica were analyzed. Crude rates per 100,000 inhabitants and standardized discharge ratios (SDR) were calculated. Age-specific discharge rates were computed using population census denominators. Results Honduras registered 1,345 hospital discharges and 236 deaths directly attributed to bacterial meningitis. The discharge rate peaked in 2016 (1.98/100,000) and dropped markedly during the COVID-19 pandemic (0.80/100,000 in 2020), showing partial recovery by 2024 (1.09/100,000). Most cases occurred in adults (median age 38 years; male-to-female ratio 1.27:1). Four departments showed an SDR significantly above 1. Notably, 75.3% ( n = 1,013) of hospital discharges were coded as unspecified bacterial meningitis (G00.9), and 19.1% as tuberculous meningitis (A17.0), highlighting a critical laboratory confirmation deficit. In contrast, Costa Rica’s reference laboratory characterized 199 culture-confirmed invasive isolates: Streptococcus pneumoniae predominated (62.3%, 38 distinct serotypes), followed by Neisseria meningitidis [21.6%, with serogroup B (55.8%) and Y (30.2%) predominant] and Haemophilus influenzae (16.1%). Conclusion This first subregional profile reveals major surveillance gaps; stronger diagnostic stewardship and integrated molecular surveillance are urgently required to close them and to guide vaccination strategy, in line with the targets of the WHO Global Roadmap to Defeat Meningitis by 2030.

Authors

Institutions

Publication Details

Journal
Frontiers in Public Health
Published
2026-11-16
DOI
https://doi.org/10.3389/fpubh.2026.1941910
Primary Topic
Bacterial Infections and Vaccines
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Characterizing the burden of bacterial meningitis in Central America: evidence from national surveillance records

Zonia Reyes, Larissa Acosta Salgado
Frontiers in Public Health
Bacterial Infections and Vaccines
article

Characterizing the burden of bacterial meningitis in Central America: evidence from national surveillance records

Zonia Reyes, Larissa Acosta Salgado
article en

Abstract

Background Bacterial meningitis remains a public health concern, yet countries in Central America lack published national epidemiological descriptions. Methods In a retrospective population-based study, ICD-10 -coded national hospital discharge and mortality databases from Honduras (2014 -2024) and reference-laboratory surveillance data (INCIENSA/SIREVA II) from Costa Rica were analyzed. Crude rates per 100,000 inhabitants and standardized discharge ratios (SDR) were calculated. Age-specific discharge rates were computed using population census denominators. Results Honduras registered 1,345 hospital discharges and 236 deaths directly attributed to bacterial meningitis. The discharge rate peaked in 2016 (1.98/100,000) and dropped markedly during the COVID-19 pandemic (0.80/100,000 in 2020), showing partial recovery by 2024 (1.09/100,000). Most cases occurred in adults (median age 38 years; male-to-female ratio 1.27:1). Four departments showed an SDR significantly above 1. Notably, 75.3% ( n = 1,013) of hospital discharges were coded as unspecified bacterial meningitis (G00.9), and 19.1% as tuberculous meningitis (A17.0), highlighting a critical laboratory confirmation deficit. In contrast, Costa Rica’s reference laboratory characterized 199 culture-confirmed invasive isolates: Streptococcus pneumoniae predominated (62.3%, 38 distinct serotypes), followed by Neisseria meningitidis [21.6%, with serogroup B (55.8%) and Y (30.2%) predominant] and Haemophilus influenzae (16.1%). Conclusion This first subregional profile reveals major surveillance gaps; stronger diagnostic stewardship and integrated molecular surveillance are urgently required to close them and to guide vaccination strategy, in line with the targets of the WHO Global Roadmap to Defeat Meningitis by 2030.

Frontiers in Public HealthVol. 14
Galileo University (GT), Organization for Women in Science for the Developing World (IT), Central American Technological University (HN)
Good health and well-being
Bacterial Infections and Vaccines
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon